• 1. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 2. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. Aggregation, pretransitional behavior, and optical properties in the isotropic phase of lyotropic chromonic liquid crystals studied in high magnetic fields
  Tanya Ostapenko,Peter J. Collings,Samuel N. Sprunt,J. T. Gleeson Soft Matter, 2013,9, 9487-9498
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

Comprehensive Overview of Methyl 5-bromo-2-(piperazin-1-yl)benzoate (CAS No. 1131587-86-4)

Methyl 5-bromo-2-(piperazin-1-yl)benzoate (CAS No. 1131587-86-4) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research due to its unique structural features and potential applications. This compound belongs to the class of piperazine derivatives, which are widely recognized for their versatility in drug discovery and development. The presence of both a bromo substituent and a piperazine moiety in its molecular framework makes it a valuable intermediate for synthesizing more complex molecules.

In recent years, the demand for piperazine-based compounds has surged, driven by their role in designing central nervous system (CNS) therapeutics and antimicrobial agents. Researchers are particularly interested in Methyl 5-bromo-2-(piperazin-1-yl)benzoate due to its potential as a building block for kinase inhibitors and GPCR-targeted drugs. These applications align with current trends in precision medicine, where tailored molecular structures are essential for addressing unmet medical needs.

The synthesis of Methyl 5-bromo-2-(piperazin-1-yl)benzoate involves multi-step organic reactions, including esterification and nucleophilic substitution. Its high purity and stability under standard laboratory conditions make it a reliable choice for academic and industrial research. Analytical techniques such as HPLC, NMR, and mass spectrometry are commonly employed to characterize this compound, ensuring its quality and consistency.

From an SEO perspective, users frequently search for terms like "piperazine derivatives in drug discovery", "brominated aromatic compounds", and "CAS 1131587-86-4 applications". These queries reflect the growing interest in structure-activity relationships (SAR) and molecular optimization. By addressing these topics, this article aims to provide a resource that bridges the gap between scientific literature and practical inquiries.

Another hot topic in the field is the role of halogenated compounds in medicinal chemistry. The bromo group in Methyl 5-bromo-2-(piperazin-1-yl)benzoate can influence the compound's binding affinity and metabolic stability, making it a subject of study for researchers exploring drug-likeness and ADME properties. This aligns with the broader industry focus on improving bioavailability and reducing off-target effects in drug candidates.

In summary, Methyl 5-bromo-2-(piperazin-1-yl)benzoate (CAS No. 1131587-86-4) represents a promising scaffold for pharmaceutical innovation. Its relevance to drug design, coupled with its synthetic accessibility, positions it as a compound of enduring interest. As research continues to evolve, this molecule may play a pivotal role in the development of next-generation therapeutics.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)